Clinical Trials Logo

Clinical Trial Summary

This study intends to study the effects of anesthetics on Circulatory Function Genomics and find the anesthetic effects in pharmacodynamics, pharmacokinetics, drug receptor or target DNA level differences, further guiding individual treatment in clinic, promoting the development of precision the medicine.The anesthesia medication during perioperative period is more and more accurate,reasonable and safe, so as to improve the satisfaction of the patients and their families in the perioperative period, to ensure the safety of patients.


Clinical Trial Description

This study is a non traumatic and non intervention study, and will use a large sample of clinical research, the number of subjects to be enrolled in the study group are 200 cases. The basic information of the study was included in the study before the operation. During the operation, the investigators need a collection of participants's arterial blood and monitor the hemodynamic index and anesthesia depth by bispectral index(BIS) . Further moreļ¼Œthe investigators will follow up the participants' condition after operation.Dividing the patients into different groups according to their clinical features.The relationship between vital signs and the depth of anesthesia was analyzed and compared between different groups.Blood samples collected during the operation were detected by gene test. Comparing the results of genetic testing and clinical data analysis, then the investigators will find the differences in the expression of the gene polymorphisms of anesthetic drugs in the circulating function. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03839186
Study type Observational
Source Xiangya Hospital of Central South University
Contact
Status Completed
Phase
Start date August 2016
Completion date April 2019

See also
  Status Clinical Trial Phase
Completed NCT03635684 - Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen Phase 2
Recruiting NCT03779347 - Schistosomiasis Diagnosis Using a CAA Antigen Test Phase 3
Recruiting NCT03270839 - Motion Sickness Medications and Vestibular Time Constant Phase 4
Not yet recruiting NCT03585946 - Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Recruiting NCT03176342 - Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs) N/A